Synergism between penicillins and lysozyme. Data which led to the synthesis of a new antibiotic salt: lysozyme ampicillinate. II.
D000818:Animals; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D004357:Drug Synergism; D005260:Female; D005334:Fever / Q000188:drug therapy; D005831:Genital Diseases, Female / Q000188:drug therapy; D006168:Guinea Pigs; D000882:Haplorhini; D006801:Humans; D007239:Infections / Q000188:drug therapy*; D007249:Inflammation / Q000188:drug therapy*; D051379:Mice; D009113:Muramidase / Q000494:pharmacology / Q000627:therapeutic use*; D010406:Penicillins / Q000627:therapeutic use*; D010532:Peritoneal Diseases / Q000188:drug therapy; D010587:Phagocytosis / Q000187:drug effects; D011008:Pneumococcal Infections / Q000188:drug therapy; D011817:Rabbits; D051381:Rats; D013203:Staphylococcal Infections / Q000188:drug therapy; D014570:Urologic Diseases / Q000188:drug therapy; D014777:Virus Diseases / Q000188:drug therapy; D014780:Viruses / Q000187:drug effects
D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D010406:Penicillins; D009113:Muramidase